Emmanuel Katsanis, MD – University of ArizonaAli McBride, PharmD, MS, BCPS, BCOP, FAzPA – University of Arizona Cancer CenterRachna Shroff, MD, MS – University of Arizona Cancer Center
ACI Tucson Program Registration
Registration for the live virtual Tucson program is NOW OPEN. Registration will close at 8:00 a.m. MST on October 31. 2020. You must be registered to attend the program.
Welcome, Introduction, SITC Resources
Session I: Introduction to Cancer Immunotherapy
Basic Principles of Cancer ImmunotherapyRichard J. Simpson, PhD, FACSM – University of Arizona
Session II: Immunotherapy in Practice
Immunotherapy for the Treatment of Skin CancersMontaser Shaheen, MD – University of Arizona
Immunotherapy for the Treatment of Lung CancerRicklie A. Julian, MD – University of Arizona Cancer Center
Immunotherapy for the Treatment of Head and Neck CancersJulie Bauman, MD, MPH – University of Arizona Cancer Center
Immunotherapy for the Treatment of Genitourinary MalignanciesEdward P. Gelmann, MD – University of Arizona
Immunotherapy for the Treatment of Hematologic MalignanciesMuhammad Husnain, MD – University of Arizona
Immunotherapy for the Treatment of Additional Solid Tumors: MSI-high Cancer and Hepatocellular CarcinomaAaron J. Scott, MD – University of Arizona Cancer Center
11:45 a.m.–12:00 p.m.
Session III: Immunotherapy Challenges and Beyond
Toxicity ManagementAlejandro Recio-Boiles, MD, FACP – University of Arizona Cancer Center
Practical Barriers in Cancer ImmunotherapyAli McBride, PharmD, MS, BCPS, BCOP, FAzPA – University of Arizona Cancer Center
What's Next for Cancer Immunotherapy?Marina Baretti, MD – The Sidney Kimmel Comprehensive Cancer Center
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE-, CNE-, MOC-certified programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, at the conclusion of this activity, participants of this should be able to:
The 2019–2020 ACI series is jointly provided by Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer.
2019-2020 Continuing Education Information
Download PDF Flyer
Participation in these CME-, CPE-, CNE- and MOC-certified online pre-program courses by ACI program attendees is strongly recommended.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org